EyeQue Funding: How Much Did They Raise & Key Investors

How Much Did EyeQue Raise?
Funding & Key Investors

EyeQue, a pioneer in the digital health sector, has successfully secured a total of $72.7M in capital to accelerate its mission of transforming vision care. The most recent strategic investment of $57M marks a significant milestone in the company's trajectory, signaling strong market confidence in its telemedicine-enabled diagnostic platform. By bridging the gap between clinical expertise and consumer-driven self-care, EyeQue continues to solidify its position as a critical infrastructure provider for modern optometry practices.

The company's growth trajectory, characterized by a series of strategic financing rounds, reflects its evolution from an early-stage innovator to a mature enterprise-level player. This latest infusion of capital is expected to bolster the company's operational capacity and expand its reach within the competitive landscape of remote patient monitoring and digital health diagnostics.

What is EyeQue?

EyeQue

Software

Healthcare Software

Mobile App Development

Founded in 2015 and headquartered in Newark, California, EyeQue operates at the intersection of ophthalmology and digital health. The company provides a sophisticated suite of at-home vision testing solutions that empower eye care professionals to maintain continuous engagement with their patients. By facilitating remote prescription updates and post-procedural monitoring, EyeQue enables practitioners to scale their practices through telemedicine while simultaneously addressing the growing consumer demand for accessible, data-driven self-care tools. The platform serves as a vital link in the patient-doctor relationship, ensuring that clinical oversight remains consistent even outside the traditional office environment.

How much funding has EyeQue raised?

EyeQue has raised a total of $72.7M across 4 funding rounds:

2016

Series A

$3.5M

2018

Series B

$11.2M

2020

Debt

$1M

2021

Series C

$57M

Series A (2016): $3.5M with participation from Align Capital

Series B (2018): $11.2M, investors not publicly disclosed

Debt (2020): $1M supported by PPP

Series C (2021): $57M, investors not publicly disclosed

Key Investors in EyeQue

Align Capital

A venture capital firm specializing in early-stage investments, focusing on high-growth technology companies with the potential to disrupt traditional service models.

PPP

Public-Private Partnership

Undisclosed Investor

A strategic partner participating in the latest funding round to support the company's long-term vision and market expansion.

What's next for EyeQue?

With the recent influx of capital, EyeQue is well-positioned to scale its enterprise-level operations and deepen its integration into the broader healthcare ecosystem. The company's strategic roadmap likely involves enhancing its proprietary diagnostic algorithms and expanding its network of partner clinics to capture a larger share of the telemedicine market. As the industry shifts toward decentralized care models, EyeQue's focus on clinical-grade accuracy and patient-centric design will be paramount in maintaining its competitive advantage. Future growth will likely center on scaling its B2B2C model, ensuring that eye doctors can leverage EyeQue's technology to drive practice efficiency and improve long-term patient outcomes in an increasingly digital-first world.

See full EyeQue company page

See More Financial Insights